欧美综合天天夜夜久久_久久久精品人妻无码专区不卡_国产成人亚洲精品狼色在线_久久综合伊人 欧美日韩午夜一区二区,大地资源在线观看中文免费,久草热久草热线频97精品,亚洲精品电影久久久

News

  • KeChow Pharma Secures $45 Million in Series C Financing

    2021-05-20

    Founded in July 2014 by Dr. Tian Hongqi, Lilly Asia Ventures and Morningside, Shanghai Kechow Pharma, Inc. is an innovative drug research and development enterprises emerging from the foundation of Tianjin Binjiang Pharma, Inc. It focuses primarily on the R&D of innovative anti-cancer drugs, aiming to provide high-quality, innovative best-in-class treatments to address clinical needs. As a biopharmaceutical company, it receives particular support from the Shanghai government. 

    Kechow Pharma is dedicated to the R&D of small molecule anti-cancer drugs. Tian Hongqi, Founder and Chairman of Kechow Pharma, expressed gratitude for the recognition and support from prominent global institutional investors focusing on biopharmaceuticals. He said: “This round of financing will accelerate our innovative drug research and the clinical development of our pipeline products, particularly the clinical research and marketing application of our MEK inhibitor, HL-085, in the U.S. and China. As an innovation-driven company, our mission is to develop best-in-class drugs to meet clinical needs, while also attracting and nurturing exceptional talents to strengthen our team. We aim to grow Kechow Pharma into a leading force in the R&D of innovative drugs.”